Near-infrared laser-triggered drug release in a tellurium nanosystem for simultaneous chemo-photothermal cancer therapy

Tumor cells can be selectively killed by heat application based on the different tolerances of normal cells and tumor cells to temperature. However, the limited clinical application of photothermal therapy (PTT) is mainly due to various practical implementation difficulties, of which the most important is how to fully heat the tumor. The combination of PTT and chemotherapy can synergistically enhance cell membrane permeability and reduce the dose of chemotherapy drugs to not only effectively kill the tumor but also reduce the damage to normal tissues. It is of great significance to develop materials that can be simultaneously used for tumor PTT and chemotherapy. Therefore, in this study, a functionalized tellurium (Te) nanosystem (DOX/PEI@TeNPs) was prepared to achieve chemo-photothermal cancer combination therapy. Our research showed that the DOX/PEI@TeNP morphology was controllable, and it had good photothermal conversion efficiency and light stability. Moreover, DOX/PEI@TeNPs containing doxorubicin (DOX) showed almost no drug release in normal tissues and neutral-pH environments, while in tumor cells and tissues, it massively released DOX to kill cancer cells. The as-synthesized DOX/PEI@TeNP system can produce reactive oxygen species (ROS) under near-infrared (NIR) light irradiation and features a high photothermal conversion efficiency due to its strong NIR absorbance. Therefore, this study provides an effective strategy for the effective design of nano-drugs, which can be used for the accurate chemical-photothermal synergistic therapy of tumors.

Synthesis and antiproliferative activity of 17-[1',2',3']-selenadiazolylpregnenolone compounds

Using pregnenolone as a starting material, some 3-substituted 17-[1',2',3']-selenadiazolylpregnenolone derivatives were synthesized, and their structures were characterized by IR, NMR and HRMS. The in vitro antitumor activity of the compounds was assayed against PC-3、SKOV3、T47D、MCF-7 and HEK293T cell lines. The results show that some compounds display selective antiproliferative activity against PC-3 and SKOV3 cells lines and are almost inactive to normal kidney epithelial cells (HEK293T). The IC₅₀ value are much better than that of abiraterone (positive control).

Construction of three-dimensional net-like polyelectrolyte multilayered nanostructures onto titanium substrates for combined antibacterial and antioxidant applications

Fabrication of nanofibers and a bacteria-triggered antibiotic-releasing coating to modify titanium substrates for antibacterial and antioxidant applications.